NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT05996003
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Exon 44
DMD
Interventions
DRUG:
NS-089/NCNP-02
Sponsor
NS Pharma, Inc.
Collaborators
[object Object]